Cite

HARVARD Citation

    Leibowitz, G. et al. (n.d.). Impact of treatment with saxagliptin on glycaemic stability and β‐cell function in the SAVOR‐TIMI 53 study. Diabetes, obesity & metabolism. 17 (5), pp. 487-494. [Online]. 
  
Back to record